We are live on
!
Find out more
DMK
David M. Knott Portfolio holdings
AUM
$275M
Turnover
23.21%
1-Year Est. Return
59.23%
This Fund
S&P 500
This Quarter
Est. Return
+7.42%
1 Year Est. Return
+59.23%
3 Year Est. Return
+80.95%
5 Year Est. Return
+223.18%
10 Year Est. Return
–
AUM
$240M
AUM Growth
+$31.8M
(+15%)
Cap. Flow
+$17.7M
Cap. Flow
% of AUM
7.4%
Top 10 Holdings %
Top 10 Hldgs %
80.41%
Holding
94
New
15
Increased
22
Reduced
3
Closed
4
Avg Time Held
2
years
Top 10 Avg Time Held
1.7
years
Top 20 Avg Time Held
1.1
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$2.06M |
| 2 |
Howard Hughes
HHH
|
+$1.86M |
| 3 |
Delta Air Lines
DAL
|
+$1.2M |
| 4 |
DuPont de Nemours
DD
|
+$1.13M |
| 5 |
AllianceBernstein
AB
|
+$1.08M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Acadia Pharmaceuticals
ACAD
|
+$715K |
| 2 |
ATCO
Atlas Corp.
ATCO
|
+$693K |
| 3 |
Hertz Global Holdings, Inc.
HTZ
|
+$495K |
| 4 |
Innovative Industrial Properties
IIPR
|
+$427K |
| 5 |
MBody AI Ltd. Ordinary Share
MBAI
|
+$349K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 73.39% |
| 2 | Financials | 8.14% |
| 3 | Technology | 3.76% |
| 4 | Real Estate | 3.58% |
| 5 | Industrials | 2.72% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
PKY
76
DELISTED
Parkway, Inc.
PKY
| $38K | 0.02% |
1,678
| – | – |
2017 Q1
1 quarter
|
|
|
PBCT
77
DELISTED
People's United Financial Inc
PBCT
| $26K | 0.01% |
1,500
| – | – |
2015 Q1
9 quarters
|
|
78
Eli Lilly
LLY
$1.12T
| $25K | 0.01% |
300
| – | – |
2013 Q3
15 quarters
|
|
79
Tempest Therapeutics
TPST
$10.6M
| $25K | 0.01% |
+5
| New | +$21.2K |
2017 Q2
0 quarters
|
|
80
Scotiabank
BNS
$111B
| $24K | 0.01% |
400
| – | – |
2015 Q1
9 quarters
|
|
81
DELISTED
DigitalBridge
DBRG
| $21K | 0.01% |
367
| – | – |
2017 Q1
1 quarter
|
|
82
Eagle Materials
EXP
$5.21B
| $21K | 0.01% |
228
| – | – |
2013 Q2
16 quarters
|
|
83
Starwood Property Trust
STWD
$4.6B
| $9K | ﹤0.01% |
400
| – | – |
2013 Q2
16 quarters
|
|
84
Alerian MLP ETF
AMLP
$12.6B
| $7K | ﹤0.01% |
120
| – | – |
2015 Q1
9 quarters
|
|
|
SCU
85
DELISTED
Sculptor Capital Management, Inc. Class A Common Stock
SCU
| $5K | ﹤0.01% |
200
| – | – |
2014 Q2
12 quarters
|
|
86
The RMR Group
RMR
$312M
| $1K | ﹤0.01% |
16
| – | – |
2015 Q4
6 quarters
|
|
|
87
MBody AI Ltd. Ordinary Share
MBAI
$42.8M
| – | – |
-97
| Closed | -$349K | – |
|
|
88
Innovative Industrial Properties
IIPR
$1.45B
| – | – |
-25,000
| Closed | -$427K | – |
|
|
ATCO
89
DELISTED
Atlas Corp.
ATCO
| – | – |
-100,000
| Closed | -$693K | – |
|
Similar funds
FA
KCP
HCIA
ISG
TPCM
DCM
MCL
DVC
David M. Knott's Q2 2017 Portfolio in Review
As of Q2 2017, David M. Knott held 94 positions worth $240M, up 15% from $208M the previous quarter. Its ten largest holdings account for 80% of the portfolio.
David M. Knott deployed $17.7M of net new capital in Q2 2017, opening 15 new positions and adding to 22 existing holdings. Its largest new stake was Howard Hughes: 15,735 shares worth $1.84M.
By sector, the portfolio is most concentrated in Healthcare at 73% of assets, down from 75% a quarter earlier, followed by Financials and Technology.
On the sell side, the largest reduction was Acadia Pharmaceuticals, an estimated $715K trimmed.
- David M. Knott's largest Q2 2017 buy was Howard Hughes: 15,735 shares worth $1.84M.
- David M. Knott added most to Pfizer in Q2 2017, an estimated $2.06M increase.
- David M. Knott's biggest Q2 2017 reduction was Acadia Pharmaceuticals, cutting an estimated $715K.
- David M. Knott fully exited Atlas Corp. in Q2 2017, selling an estimated $693K.
- David M. Knott's ten largest holdings make up 80% of its $240M portfolio in Q2 2017.
- David M. Knott opened 15 new positions and closed 4 in Q2 2017.
- David M. Knott's portfolio value rose 15% quarter-over-quarter to $240M.
Based on David M. Knott's 13F filing for Q2 2017, filed 11 Aug 2017.